BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35427882)

  • 1. Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot.
    Bories E; Fortenfant F; Pugnet G; Renaudineau Y; Bost C
    Semin Arthritis Rheum; 2022 Aug; 55():151998. PubMed ID: 35427882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
    Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
    J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes.
    Liu D; Zhao L; Jiang Y; Li L; Guo M; Mu Y; Zhu H
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2456-2472. PubMed ID: 35860906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.
    Montagnese F; Babačić H; Eichhorn P; Schoser B
    J Neurol; 2019 Jun; 266(6):1358-1366. PubMed ID: 30840145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies.
    Mahler M; Malyavantham K; Seaman A; Bentow C; Anunciacion-Llunell A; Sanz-Martínez MT; Viñas-Gimenez L; Selva-O'Callaghan A
    Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.
    Platteel ACM; Wevers BA; Lim J; Bakker JA; Bontkes HJ; Curvers J; Damoiseaux J; Heron M; de Kort G; Limper M; van Lochem EG; Mulder AHL; Saris CGJ; van der Valk H; van der Kooi AJ; van Leeuwen EMM; Veltkamp M; Schreurs MWJ; Meek B; Hamann D
    J Transl Autoimmun; 2019 Dec; 2():100013. PubMed ID: 32743501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study.
    Leurs A; Dubucquoi S; Machuron F; Balden M; Renaud F; Rogeau S; Lopez B; Lambert M; Morell-Dubois S; Maillard H; Béhal H; Hachulla E; Launay D; Sobanski V
    Joint Bone Spine; 2021 Jan; 88(1):105048. PubMed ID: 32653653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
    Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
    Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
    Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
    Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.
    Piette Y; De Sloovere M; Vandendriessche S; Dehoorne J; De Bleecker JL; Van Praet L; Vander Mijnsbrugge AS; De Schepper S; Jacques P; De Keyser F; Smith V; Bonroy C
    Clin Exp Rheumatol; 2020; 38(2):212-219. PubMed ID: 31287411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
    Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
    Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
    Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
    Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
    Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.
    Tampoia M; Notarnicola A; Abbracciavento L; Fontana A; Giannini M; Louis Humbel R; Iannone F
    J Clin Lab Anal; 2016 Nov; 30(6):859-866. PubMed ID: 27074881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical contribution of myositis-related antibodies detected by immunoblot to idiopathic inflammatory myositis: A one-year retrospective study.
    Lecouffe-Desprets M; Hémont C; Néel A; Toquet C; Masseau A; Hamidou M; Josien R; Martin JC
    Autoimmunity; 2018 Mar; 51(2):89-95. PubMed ID: 29463118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies.
    Conticini E; d'Alessandro M; Cameli P; Bergantini L; Pordon E; Cassai L; Cantarini L; Bargagli E; Frediani B; Porcelli B
    Immunol Res; 2023 Oct; 71(5):735-742. PubMed ID: 37133680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study.
    Lackner A; Tiefenthaler V; Mirzayeva J; Posch F; Rossmann C; Kastrati K; Radner H; Demel U; Gretler J; Stotz M; Graninger WB; Stradner MH
    Ther Adv Musculoskelet Dis; 2020; 12():1759720X20975907. PubMed ID: 33343724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.
    Mahler M; Miller FW; Fritzler MJ
    Autoimmun Rev; 2014; 13(4-5):367-71. PubMed ID: 24424190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.